Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More Than 30 Data Presentations at ECCMID 2016
Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today announced that researchers are scheduled to provide more than 30
scientific data presentations on the company’s established and
investigational infectious disease medicines and vaccines at this year’s
26th European Congress of Clinical Microbiology and Infectious Diseases
(ECCMID), April 9-12 in Amsterdam, Netherlands.
Language:
English
Contact:
MerckMedia:Doris Li, 908-246-5701Robert Consalvo, 908-295-0928orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more
Source: Merck.com - Corporate News - Category: Pharmaceuticals Tags: Corporate News Latest News #Merck #MRK $MRK ECCMID Infectious Diseases NYSE:MRK Source Type: news